Screener
TherapeuticsMD TXMD Q3 2025 earnings
Reported November 12, 2025 · Before market open
Revenue$784.0K
EPS$0.01
Next report
Nov 17, 2026 (in 3 months)Revenue estimate$19.8M
EPS estimate-$6.13
Versus estimates
FAQ
- When did TherapeuticsMD report Q3 2025 earnings?
- TherapeuticsMD (TXMD) reported Q3 2025 earnings on November 12, 2025 before market open.
- What were TherapeuticsMD's Q3 2025 revenue and EPS?
- TherapeuticsMD reported revenue of $784.0K and eps of $0.01 for Q3 2025.
- How did TherapeuticsMD's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 43.3% from $547.0K a year earlier.
- Where can I find TherapeuticsMD's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-25-109479) and the 10-Q periodic report (0001213900-25-109381) directly on SEC EDGAR. The filing index links above go to sec.gov.
